Results 331 to 340 of about 2,266,569 (385)
Multiple or Single Endocrine Abnormalities Associated With Immune Checkpoint Inhibitors.
Kamitani F +8 more
europepmc +1 more source
Immune Checkpoint Inhibitor Therapy in Hormone Receptor-Positive Breast Cancer. [PDF]
Lin D, Bitar JSL, Ma I, Yuan Y.
europepmc +1 more source
The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study. [PDF]
Saffuri N +7 more
europepmc +1 more source
Mechanisms of Immune Checkpoint Inhibitor Resistance in Hepatocellular Carcinoma and Strategies for Reversal. [PDF]
Dai XY, Yang XJ, Wu H, Lv YH, Lan T.
europepmc +1 more source
Immune checkpoint inhibitor-associated diabetes mellitus: mechanisms, clinical manifestations, and management strategies. [PDF]
Chen Y, Wang X, Duan S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Radiotherapy, immunity, and immune checkpoint inhibitors.
The Lancet OncologyRadiotherapy exerts immunostimulatory and immunosuppressive effects, both locally, within the irradiated tumour microenvironment, and systemically, outside the radiation field. Inspired by preclinical data that showed synergy between radiotherapy and immune checkpoint inhibitors, multiple clinical trials were initiated with the hypothesis that combined
C. Lynch, S. Pitroda, R. Weichselbaum
semanticscholar +3 more sources
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Nature Reviews Clinical Oncology, 2021Mary Beth Beasley +2 more
exaly +2 more sources

